As shown in Figure 3, DSS-induced colitis downregulated occludin expression, while the administration of SPA3074 showed significantly higher occludin expression levels, indicating that administration of SPA3074 suppressed DSS-induced occludin loss. The gene discussed is OCLN; the disease is colitis.